BIO-key International - Earnings Call - Q4 2024

Executive Summary

• Q4 2024 revenue was $1.46M and diluted EPS was ($0.53), reflecting a significant miss vs Wall Street consensus revenue of $2.29M and EPS of ($0.35); margin profile improved on higher license mix despite lower total revenue. Revenue Consensus Mean $2.29M*, Primary EPS Consensus Mean ($0.35)*; Actual revenue $1.46M, EPS ($0.53).
• License revenue grew 77% YoY to $1.02M while services fell 28% to $0.34M and hardware declined 88% to $0.09M, consistent with the strategic exit from Swivel Secure and pivot to higher-margin BIO-key solutions.
• Gross profit reached $1.20M vs a loss in Q4’23, as mix shifted to BIO-key’s own software and benefited from sale of previously reserved hardware; OpEx was flat YoY at $2.63M, and net loss improved to ($1.57M) from ($2.37M) YoY.
• Strategic catalysts: completed initial deployment for a new European defense agency in four days (expansion expected), Ed Tech JPA partnership (access to 195 K‑12 districts), and large financial services biometric upgrade with ~$600K recognized Q1’25 and ~$250K in Q4’24.

What Went Well and What Went Wrong

• What Went Well

  • License revenue strength: “Our efforts enabled us to increase high‑margin software license fee revenue by 20%… In Q4’24 license fee revenue increased 77% to $1.0M”.
  • Margin improvement: Adjusted gross margin rose as mix shifted to BIO‑key solutions; Q4’24 gross profit was $1.20M vs Q4’23 loss driven by prior‑year hardware reserves and sale of reserved inventory.
  • Strategic wins and execution: “We secured a $910K contract with a long‑time financial services client… expected to trim ~30 seconds from each customer interaction” and completed a rapid defense deployment (four days) with planned expansion.

• What Went Wrong

  • Top‑line shortfall vs expectations: Management previously expected FY’24 revenue ≥ FY’23; Q4’24 and FY’24 were impacted by the Swivel Secure exit and timing slips into Q1’25, driving the miss vs consensus.
  • Services and hardware declines: Q4’24 services down 28% and hardware down 88% YoY due to transition away from SSL and absence of a large expansion order seen in Q4’23.
  • Continued losses and limited cash: Q4’24 net loss ($1.57M) and year‑end cash $0.44M (though strengthened in Q1’25 via warrant exercises); variability from large-order timing remains a headwind.

Transcript

Operator (participant)

Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's 2024 fourth quarter conference call. During management's prepared remarks, all participants will be in listen-only mode. Afterwards, listeners will be invited to participate in a question-and-answer session. As a reminder, this conference is being recorded today, Thursday, March 27, 2025. I will now turn the call over to Bill Jones, Investor Relations. You may proceed.

William Jones (Head of Investor Relations)

Thank you, Rocco. Today, our hosts are BIO-key's Chairman and CEO, Mike DePasquale, and its CFO, Ceci Welch. As a reminder, today's conference call and webcast, as well as answers to investor questions, include forward-looking statements which are subject to risks and uncertainties that may cause actual results to differ materially from current expectations. Words including anticipate, believe, estimate, expect, plan, project, or similar words generally express and identify forward-looking statements. Such statements are made based on management's beliefs, assumptions, and information currently available as of today, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For a complete description of risks that may affect future performance of the company, please see risk factors in the company's annual report filed on Form 10-K with the Securities and Exchange Commission.

We caution listeners not to place undue reliance on forward-looking statements which speak only as of today. The company undertakes no obligation to revise or disclose revisions to forward-looking statements to reflect circumstances and events that occur after today's call. I will now turn the conference over to Mike to begin. Mike.

Michael DePasquale (Chairman and CEO)

Thanks, Bill. Good morning, and thank you for joining today's call. After my prepared remarks, I will turn the call over to Ceci for a financial overview, and then we will open the call to investor questions. As highlighted in today's release, we substantially strengthened the margins, profitability, and strategic potential of our business in 2024, putting us in a far stronger position to grow and move the business to profitability and positive cash flow. Also, after the close of 2024, we substantially strengthened our financial position with approximately $3.8 million in proceeds from a warrant exercise. Also, at the same time, we were able to reduce our outstanding debt to approximately $730,000 from approximately $1.5 million at the end or close of 2024 to what is now currently approximately $730,000. This puts us in a much stronger position to continue to execute on our growth plans.

We accomplished most of this by continuing to expand our base of customers and repeat customers, and by exiting our low-margin software and services relationship with Swivel Secure to focus our full efforts on core BIO-key solutions such as PortalGuard IAM and our identity-bound biometrics. These solutions have far stronger technology, competitive positioning, and customer value, and also deliver far higher gross margin contributions than the third-party solutions that played a helpful role for us in building our presence in Europe, the Middle East, and Africa. Our efforts enabled us to increase high-margin software license fee revenue by 20% to $5.2 million in 2024. Excluding the impact of hardware reserves in both periods, 2024 gross profit rose 8% to $5.4 million for an adjusted gross margin of 78% compared to an adjusted margin of 64% in 2023.

The business transition did, however, result in the loss of lower-margin services revenue, which offset the growth in license fees and contributed to an 11% decline in revenue to $6.9 million in 2024. We were also able to further reduce operating expenses by 6% in 2024, and we were able to trim our cash burn by 23% to $2.9 million in 2024 from $3.8 million in 2023. With this transition behind us, we entered 2025 in a much stronger position to drive top-line growth and to bring more of that revenue to the bottom line. Importantly, we are already seeing very encouraging order activity and customer interest in our solutions so far in 2025, and that underscores our optimism for the business this year and in the future.

Though we have long spoken of expanding breadth of cybersecurity vulnerabilities, actual breaches, and the limitations of many widely used identity and access management solutions, many of the IT teams we speak with are recognizing the urgent need for them to deploy stronger and more user-friendly and cost-effective solutions to protect their systems and data. There is a growing recognition of the inherent vulnerabilities, growing costs, and usability challenges of widely deployed current authentication methods that rely on passwords, mobile phones, or tokens. 2024 was the first year of the SEC's new cybersecurity risk management and reporting rules for public filers, elevating the importance of these issues with senior management and directors, in addition to compliance requirements for cyber insurance policies. This growing awareness is helping customers appreciate the substantial value we have built over the past years in forging our flexible suite of passwordless, phone-less, and token-less authentication solutions.

On top of increasing cybersecurity demands and high-profile incidents, the shortage of cybersecurity talent is also challenging organizational ability to prevent or respond to cyber attacks and threats. This current backdrop, though scary, is proving ideal in supporting the secure and cost-effective solutions we offer. As a result, we are seeing very encouraging interest and demand for our solutions in mission-critical national defense, financial services, and education applications. We are also seeing growing strength in Europe, the Middle East, and the Asia region, or EMEA countries, where the security and value of our passwordless, phone-less, and token-less authentication solutions, enabled by our unique biometric capabilities, are gaining growing recognition and adoption. As an example, in late 2024, we secured a $910,000 contract with a longtime foreign financial services client to implement our most secure and user-friendly one-to-many biometric identification technology across its branches.

The client has already enrolled fingerprint biometrics for over 25 million of its customers and is now upgrading our fingerprint-only identification technology, which enables our client to positively identify each individual from its universe of enrolled customers solely via a fingerprint scan. This enhanced solution is expected to trim approximately 30 seconds from each of their customer interactions, resulting in an improved customer experience as well as substantial long-term savings for them. Another example is our long-standing relationship with one of the world's most esteemed defense ministries, which substantially expanded its deployment of our biometric solutions in 2024, a trend we expect to continue. We currently provide authentication security for over 80,000 ministry personnel and expect the size of this deployment to double or triple in the coming years as work under a new three-year procurement arrangement that was initiated in Q3 2024 has begun.

For perspective, this customer has already contributed a total of over $3.3 million in hardware and license revenue to date. Similarly, we referenced in today's release the partnership we forged with the National Bank of Egypt and our partner, Raya Information Technology, to integrate our PortalGuard IAM platform and with their leading industry governance solution. This project will initially secure the digital access and identities of the bank's 30,000 employees, and we believe there's a future potential to expand the deployment ultimately to its millions of customers. Turning to the U.S., we have built a very strong presence in education to over 100 institutions representing 300 individual single opportunities, serving over 4 million end users. We continue to build our presence in this market to new colleges and universities that are adding PortalGuard, their PortalGuard platform, to their use case.

In 2025, the Wyoming Department of Education deployed PortalGuard IDaaS, and we recently executed a strategic partnership with California Ed Tech JPA, which guides IT solution procurement for 195 K-12 schools and districts, serving over 2.5 million students. This new relationship positions BIO-key to provide our IAM solutions to those member schools. As we also referenced in today's release, we have been working to see future business opportunities in emerging markets, including food and food safety, Internet of Things solutions, drone technology, and autonomous vehicles. We partnered with Fiver Food Systems and exchanged BIO-key shares to secure a stake in an innovative drone technology developer, Boomerang, which will surely require strong identity and access management solutions.

The equity exchange strengthened our balance sheet and also led to a strategic collaboration seeking to integrate our biometric technology in aerospace, defense, healthcare logistics, and smart cities applications in development by Guinn Partners, an engineering and design firm. These initiatives are in the early stages and will take time to develop, but we believe they represent exciting potential commercial opportunities for BIO-key down the road. On the current business front, 2025 is off to a solid start, and we feel well-positioned to deliver improved top and bottom-line performance. We've transitioned our EMEA focus to BIO-key solutions and are seeing meaningful signs of customer engagement, particularly in Europe and the Middle East. Globally, we are also seeing growing appreciation for the value of our unique passwordless, phone-less, and token-less IAM solutions and core biometric technology, all of which underscores our optimism.

We also continue to focus on opportunities to reduce cost and lower our break-even level. At the same time, we seek to drive growing sales through our channel alliance partner program and our internal sales teams. In addition, we launched PortalGuard IDaaS on the AWS Marketplace last fall, enabling AWS customers to seamlessly purchase and integrate PortalGuard into their enterprise. Today, our business is predominantly subscription-based and partner-centric, as roughly 50% of our new PortalGuard business is sold through partners, while nearly all of our EMEA business is partner-based. As a result of these initiatives and with approximately two-thirds of our revenue derived from contracted ARR, we are very confident that BIO-key will return to growth and deliver improved profitability in 2025. With that overview, I would like to turn the call over to our CFO, Ceci Welch, to review the financials before we take investor questions.

Ceci Welch (CFO)

Thank you, Mike. Our results were released this morning, and we plan to file our 10-K by Monday. Now, let me review some of the operating highlights, keeping in mind that year-over-year comparisons are to our restated 2023 results that we filed in our prior 10-K. As Mike touched on, we are excited about our EMEA civil secure services agreement in Q2 2024, exited, sorry, and related royalty structure and fees created fairly low-margin business and no longer justify the resources it required. While the termination created revenue headwinds in 2024, we believe it ultimately strengthens our business by enhancing gross profit margins moving forward and focusing our EMEA activity solely on BIO-key solutions. As a result, BIO-key's revenues decreased 11% to $6.9 million in 2024, principally due to our exit from the civil secure limited distribution agreement.

This strategic decision caused a reduction in lower-margin service revenue related to third-party licensed products that has enabled BIO-key to focus on its own higher-margin software products. As a result of this transition, the 2024 license fee revenue increased 20% to $5.2 million in 2024. Service revenue declined to $1.1 million from $2.2 million in 2023, and hardware revenue declined to $632,000 from 2024 and $1.2 million in 2023 due to a large expansion order received from an existing customer in Q4 2023 that did not reoccur in 2024 but is expected again in 2025. In Q4 2024, our license fee revenue increased 77% to $1 million, lower-margin services decreased 28% to $344,000, and hardware revenue declined 88% to $94,000, resulting in Q4 revenue of $1.5 million compared to $1.8 million in Q4 2023.

Our gross profit grew to $5.6 million in 2024 from $1.4 million in 2023 due to the impact of the $3.6 million hardware revenue in 2023, hardware reserve, sorry, growth in high-margin license fee and reduction in lower-margin services and hardware revenue compared to 2023. 2024 gross profit also benefited from the sale of $213,000 of hardware in 2024, which was previously fully reserved. We reduced our operating expenses by $600,000 to $9.7 million in 2024 from $10.3 million in 2023 due to the reduced SG&A, partially offset by higher research and development engineering costs to support new product development. BIO-key continues to proactively reduce expenses where possible, and we will continue to closely manage and monitor our operating costs to identify possible savings in 2025.

Reflecting on greater gross profit and lower operating expenses, BIO-key's 2024 net loss improved to $4.3 million or $2.10 per share from net loss of $8.5 million or $15.21 per share in 2023. Likewise, BIO-key's Q4 net loss improved to $1.6 million or $0.53 per share compared to a $2.4 million loss or $3.99 per share in Q4 2023. 2023 results also included a hardware reserve of $3.6 million in 2023 and $1.08 million in Q4 of 2023. 2024 included positive hardware reserve adjustments of $213,000 in Q4 for the sale of hardware that was previously reserved. Per share amounts are based on weighted average shares of 2,059,884 in 2024 and 560,270 in 2023, primarily reflecting new shares issued for the warrant conversions of over 1 million shares issued pursuant to the warrant inducement agreement in September 2024.

The shares were priced at $1.85 per share for the warrant inducement, yielding gross proceeds of approximately $1.9 million before agencies and offering expenses. Turning to our balance sheet as of December 31, 2024, BIO-key had current assets of $1.9 million, including $438,000 of cash and cash equivalent. This concludes my prepared remarks. Operator, we can now begin the Q&A session.

Operator (participant)

Thank you. If you'd like to ask a question, please press star then one on your telephone keypad. If at any time your question has been addressed and you'd like to remove yourself from queue, please press star then two. Once again, that's star then one if you have a question. Today's first question comes from Jack Vander Aarde with Maxim Group. Please go ahead.

Jack Vander Aarde (Vice President and Senior Equity Research Analyst)

Okay, great. I appreciate the update, guys. Thanks for taking my questions. Maybe just I'll start with a point of clarification.

Did I hear correctly? The 10-K is expected to be filed on Monday or by Monday. On the restatements that were referenced, was there any new additional restatements in prior periods since you last reported three key results in November, or is this just a reference to the restatements that were already disclosed earlier in the year? Thanks.

Michael DePasquale (Chairman and CEO)

Yeah, let Ceci take that. Sure.

Ceci Welch (CFO)

Yes, we expect to file the 10-K on Monday, this coming Monday. We also are referring to the 2023 restatements. Nothing new this year.

Jack Vander Aarde (Vice President and Senior Equity Research Analyst)

Okay, thank you. That's helpful. I guess moving on, Mike, last quarter, I was encouraged by the strong license revenue uptick that happened in the third quarter, especially just given historical seasonality of the business, where it's kind of softer, especially in Europe.

I believe you were expecting from in November, I think you were expecting to finish 2024 with at least having overall total revenue flat compared to 2023. Maybe just help me understand what changed or did not happen relative to your expectations that you were talking about, I guess, back in November. Did something just get pushed into 2025? Did it spill through with something longer sales cycles? Just help me understand kind of what changed relative to your, I think, your kind of flat growth expectations in 2024.

Michael DePasquale (Chairman and CEO)

Yeah, I will say it is exactly as I described. It is fundamentally the transition and exit from the Swivel Secure business. The services agreement resulted in, I guess, a delta of about $800,000 or $900,000 for the full fiscal 2024.

We had a couple of opportunities that we had in the pipeline for the Swivel side that we were converting to BIO-key, and so they took a little bit more time, and some of that slipped into the first quarter. The gross margin impact is just tremendous. I mean, you can see our blended gross margins now are nearing 80%. Getting out of that low-margin, 10% margin software support contract was huge for us. Selling BIO-key core product versus a third-party product, which had a 50% gross margin, just has a huge impact on us.

We have made a couple of announcements on contracts that we closed out of EMEA, one with the National Bank of Egypt in January, but one yesterday for a very notorious defense agency in Europe that is all BIO-key product and, in fact, is including biometrics as well with it. It is fundamentally that transition, Jack, and that is where we came up short.

Jack Vander Aarde (Vice President and Senior Equity Research Analyst)

Okay. Got you there. Maybe just, I guess, if I look at the fourth quarter, Mike, the license revenue is up year over year substantially, at least. That is a positive there.

I guess just given the nuanced comments about the moving off or transitioning away from the Swivel Secure contracts to some of your newer BIO-key solutions, is that disruption and transition process, is that behind you now, or is this going to be is there some headwinds related to that, I guess, as you're entering 2025? How should we think about that?

Michael DePasquale (Chairman and CEO)

Totally complete, totally done. We are, again, you saw the contract yesterday, huge, huge contract for us in the context of visibility, size, and magnitude. We are building a very significant presence in the international defense marketplace, and this is just another one of those. We are totally behind the transition. We're complete with that.

Jack Vander Aarde (Vice President and Senior Equity Research Analyst)

Okay. That's helpful to know.

Just in terms of your outlook, you are expecting, it sounds like you're officially expecting, it sounds like you're confident you expect to return to growth in the revenue line and improve profitability during 2025 relative to 2024. Since we're already almost done with the first quarter here, it's March 27th, just any sort of data points, insights into how you expect the first quarter to kind of look compared to, I don't know, the fourth quarter of 2024 and the first quarter of 2024? How's the first quarter of this year looking?

Michael DePasquale (Chairman and CEO)

Yeah. We're not closed yet, that's number one. Number two, we do expect to absolutely emphatically grow our business in 2025. More importantly, you can see just, again, via the numbers, the gross margins and the march towards profitability should be very aggressive this year. Our break-even is coming down.

Our expenses, we continue to manage them very, very closely. We're still investing in R&D in areas that are necessary to stay on the leading edge, and we are doing that in our biometrics business. Yeah, I'm expecting a very, very good 2025 and not only growth on the revenue side, but also a much more accelerated path to profitability and cash flow break-even.

Jack Vander Aarde (Vice President and Senior Equity Research Analyst)

Okay. Great. Maybe just from a segment perspective, because things have obviously been, you guys, it's been very fluid here. Licensing, recurring license revenue is obviously the story. From, I guess, from a hardware perspective and then a services perspective, those two segments, are we expecting—can you just help walk me through those, I guess? Are we expecting growth in the hardware line at all, or is that maybe that's a potential upside benefit, or is that not really the focus?

Then the services revenue side as well, it's been kind of stable between $20,000 and $34,000, I guess, per quarter on the revenue, or $340,000 to $200,000 on the revenue quarterly line. Expecting growth in any of those segments?

Michael DePasquale (Chairman and CEO)

Yeah. Great question. On the hardware side, interesting, as I mentioned, biometrics, and that's our unique competitive advantage, are becoming more and more part of every contract that we're selling. With that comes hardware sales, because typically customers are deploying in the enterprise, they're deploying our finger biometric technology. Along with the software, the subscription license software, they're also acquiring the hardware to be able to facilitate the authentication process. I do believe we'll see growth on the hardware side. I do believe that.

On the services side, I think we're going to be very, very stable to growing, but it's not going to be, again, against that software support contract like we had in 2023. That's gone. It didn't exist in 2024. I do believe you'll see growth on the services side as well as we proceed forward. That will be professional services or different types of support that may be even episodeal that we provide our customers as they onboard our solutions. Yeah, I do believe we'll see growth in both of those lines in 2025.

Jack Vander Aarde (Vice President and Senior Equity Research Analyst)

Great. Okay. Maybe just one more and I'll hop in the queue. The large order you secured in the fourth quarter, the $910,000 contract, was that fully recognized in the fourth quarter, or is any of that getting spilled into Q1 of 2025?

Michael DePasquale (Chairman and CEO)

Actually, a significant portion of that order is in Q1 of 2025. That was an addition. As I mentioned, we have a very large financial services customer that upgraded to our latest technology. That was, and we sold them a two-year subscription, which will renew in Q1 of next year, which now represents $1.5 million in recurring revenue. This was kind of an add-on or an upgrade to that existing subscription. There was about $250,000 or so recognized in Q3, Q4, I believe Q4, and about $600,000 in Q1. Good question.

Jack Vander Aarde (Vice President and Senior Equity Research Analyst)

Okay. Great. No, that's good to hear. I think that's it for me. I'll hop back in the queue. Thanks for the questions or taking my questions.

Michael DePasquale (Chairman and CEO)

Thanks, Jack.

Operator (participant)

Thank you.

As a reminder, if you'd like to ask a question, please press star then one at this time. We'll pause for just a moment to assemble our roster. Our next question comes from Dan Cannis, a private investor. Please go ahead.

Oh, hey. I'm just looking at the release from yesterday or the day before on the—you said it's a European defense agency. I'm just wondering, is there any kind of idea of the scale, the amount of the contract here, or the recurring revenues?

Michael DePasquale (Chairman and CEO)

Yep. Thanks. That's the new contract that we announced yesterday?

Yeah. Spain and Holmdel, New Jersey. It's the global leader in identity and access management.

The contract we announced yesterday is with a new customer. That's not an existing customer. It's a new customer. I can't share any more detail on that other than what you saw.

As the press release described, we completed the initial deployment in record time. I mean, we did it in days. We will be working on the next phase, and this is phased. We will be working on the next phase in the second quarter, this quarter coming up. It is a substantial contract, and it is with a very notorious defense agency in Europe. I see. I mean, can we assume that since it was done so fast that the first phase is pretty small, or is that? No, I would not make any assumptions on that at all. Again, I cannot really share any more of the data on that and our partner and the likes. It is just highly confidential.

I noticed there has been some noise from the World Bank about moving Nigeria forward on their ID plans.

Is there any update on that that you can give us in terms of the long-stalled BIO-key contracts and that?

You're right about that, Dan. There is a lot of talk. The World Bank has circled back at the beginning of this year, the end of last year, the beginning of this year to try to accelerate what they have been trying to accelerate for 10 years, which is the full enrollment of all citizens in Nigeria for all kinds of applications, but mostly in the financial sector. We will see. They claim to now be putting an infrastructure in place to be able to pay all of the vendors that enroll these individuals. Obviously, that includes purchasing hardware and software and all that other stuff. We will see.

We're watching it, and we'll see what happens over the next few months or as we approach the middle of the year. I really can't share any more than that. Again, we're following it closely.

I mean, is there any potential for sales of the original hardware that you have in the inventory?

Oh, absolutely. Again, there has to be the facility in place to do it. We obviously have other opportunities for that equipment outside of, again, Nigeria and some of the African countries. We're not just waiting on that particular opportunity to materialize. We're working other ones as well at the same time. We have sold some of that inventory. We sold some of it in 2024, and we expect to sell much, much more of it in 2025.

Yeah. I noticed there's about $200,000 in reversed reserve or something this quarter.

Does that mean that you sold about $200,000 worth of that hardware in the fourth quarter?

Yes.

Can you tell us any more data about that, or is it?

No. It's just, again, we have various projects that are in the works, and we're seeding them. We hope that we'll see some more significant, I'll call it volume orders, right, larger orders in the coming periods.

Am I calculating it right that you had about a $500,000 total loss in the fourth quarter, or am I not calculating that right? Because there's no quarter data.

Ceci Welch (CFO)

I'm sorry. You were breaking up a little bit there. I'm missing what you were saying.

I'm sorry. What was your cash flow loss in the fourth quarter from operations?

I don't have that number in front of me. We didn't—yeah.

I didn't do a separate cash flow for the fourth quarter, actually, just for the year.

All right. I mean, but it was less, right, than—Oh,

yes. Yes.

It was cut back.

Yes. And cutting back.

And Mike, on the R&D, is that an increase? I think you mentioned an increase in R&D. Can you give us some clue as to what that is being spent on, or anything else coming up?

Michael DePasquale (Chairman and CEO)

Yeah. I think we've communicated quite a bit about this as well. We feel there's a significant opportunity with passkeys, and we introduced a product called Passkey:YOU. We are doing some integrations around that. Biometrics are becoming almost part and parcel of almost every deal that we're selling now.

I mean, for someone who's been doing this a long time and pushing biometrics because of not only the security, but because of the convenience and the overall user experience, we're seeing that really come to life now. The integrations with some of the larger partners, those APIs, things like that, are really where we're spending most of our time and energy and also money, also in the mobile auth area. We continue to believe that biometrics for real enterprise mobile authentication are a big play. That's where we're investing right now. We're not—our product is very, very complete. These are just tweaks and additions to stay on the edge.

Okay. In terms of OpEx, should we expect it flat from the fourth quarter for the first quarter, or going back to the third quarter, or what should we expect going forward in terms of OpEx?

Have to defer that to Ceci.

Ceci Welch (CFO)

Yeah. I think we're going to be pretty flat for a little while. We're just looking to optimize what we're doing right now. So pretty flat for a few quarters.

Okay. All right. That's all I got. Thank you.

Operator (participant)

Thank you. Should I know further questions, this concludes the question-and-answer session. I'd like to turn the call back over to Mike DePasquale for closing remarks.

Michael DePasquale (Chairman and CEO)

Thank you, everyone, for your time today and for joining this call. You may reach out to our IR team, whose contact information is in today's press release, with any follow-up questions. Also, look for us at the Maxim TMT conference in early June, which we expect to participate in and be available for investor meetings. We also look forward to updating you on our Q1 call in May.

As always, we'll provide interim news updates via press release as they evolve. Thank you again, and have a great day.

Operator (participant)

Thank you, sir. This concludes today's conference call. We thank you all for attending today's presentation. You may now disconnect your lines and have a wonderful day.